Pralatrexate for peripheral T-cell lymphoma - relapsed and/or refractory
National Horizon Scanning Centre
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
National Horizon Scanning Centre. Pralatrexate for peripheral T-cell lymphoma - relapsed and/or refractory. Birmingham: National Horizon Scanning Centre (NHSC). Horizon Scanning Technology Briefing. 2009
Department of Public Health, Epidemiology, and Biostatistics, School of Health & Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269 Email: c.packer@bham.ac.uk